MD411C2 - Procedeu de obţinere a pancreatinei din pancreas - Google Patents

Procedeu de obţinere a pancreatinei din pancreas

Info

Publication number
MD411C2
MD411C2 MD95-0074A MD950074A MD411C2 MD 411 C2 MD411 C2 MD 411C2 MD 950074 A MD950074 A MD 950074A MD 411 C2 MD411 C2 MD 411C2
Authority
MD
Moldova
Prior art keywords
alcohol
isoprophylic
autolysis
filtrated
pancreas
Prior art date
Application number
MD95-0074A
Other languages
English (en)
Romanian (ro)
Russian (ru)
Inventor
Schultze Dr.Hans
Original Assignee
Nordmark Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19823248587 external-priority patent/DE3248587A1/de
Priority claimed from DE19823248588 external-priority patent/DE3248588A1/de
Application filed by Nordmark Arzneimittel Gmbh filed Critical Nordmark Arzneimittel Gmbh
Publication of MD411C2 publication Critical patent/MD411C2/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/94—Pancreatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MD95-0074A 1982-12-30 1994-12-29 Procedeu de obţinere a pancreatinei din pancreas MD411C2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823248587 DE3248587A1 (de) 1982-12-30 1982-12-30 Verfahren zur gewinnung von pankreatin
DE19823248588 DE3248588A1 (de) 1982-12-30 1982-12-30 Verfahren zur gewinnung von pankreatin von hohem schuettgewicht

Publications (1)

Publication Number Publication Date
MD411C2 true MD411C2 (ro) 1996-06-30

Family

ID=25807022

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0074A MD411C2 (ro) 1982-12-30 1994-12-29 Procedeu de obţinere a pancreatinei din pancreas

Country Status (15)

Country Link
US (1) US4623624A (fr)
EP (1) EP0115023B1 (fr)
AR (1) AR232000A1 (fr)
BR (1) BR8307280A (fr)
CA (1) CA1208580A (fr)
DD (1) DD212981A5 (fr)
DE (1) DE3377506D1 (fr)
DK (1) DK173599B1 (fr)
ES (1) ES528537A0 (fr)
HU (1) HU196435B (fr)
MD (1) MD411C2 (fr)
PL (1) PL141118B1 (fr)
SU (1) SU1644712A3 (fr)
UA (1) UA5996A1 (fr)
YU (1) YU45584B (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30058A (en) * 1989-11-24 1996-11-08 Biochemie Gmbh Pancreation preparations
CA2198317C (fr) * 1997-02-24 2003-01-07 Mouhsine El Abboudi Methode pour preparer de la pancreatine qui contient de faibles quantites residuelles de solvant organique et produit contenant cette derniere
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
KR100367659B1 (ko) * 2000-05-08 2003-01-14 주식회사 바이넥스 선택적 안정화제의 첨가에 따른 자가분해(autolysis)를 통한 고역가 판크레아틴의 제조방법
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
CA2419572A1 (fr) * 2003-02-18 2004-08-18 Axcan Pharma Inc. Preparation a forte concentration de protease
CN1809753B (zh) * 2003-07-29 2010-10-20 索尔瓦药物有限公司 通过二维凝胶电泳分析包含生理可接受消化酶混合物的方法
CA2560613C (fr) * 2004-03-22 2015-11-24 Solvay Pharmaceuticals Gmbh Compositions pharmaceutiques par voie orale a base de lipases, en particulier de pancreatine, contenant des tensioacitfs
US7153504B2 (en) * 2004-07-30 2006-12-26 Can Technologies, Inc. Stabilized pancreas product
MX2007013725A (es) 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.
PL2278002T3 (pl) * 2005-07-29 2017-12-29 Abbott Laboratories Gmbh Pankreatyna o zmniejszonej zawartości wirusowej
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
TW200745337A (en) * 2006-02-24 2007-12-16 Aminotech As Modified process
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
PT2079445E (pt) 2007-02-20 2016-02-29 Allergan Pharmaceuticals Internat Ltd Composições de enzimas digestivas estáveis
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
WO2009109856A2 (fr) 2008-03-07 2009-09-11 Axcan Pharma Inc. Procédé pour détecter un parvovirus infectieux dans des préparations pharmaceutiques
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
PL2318035T3 (pl) * 2008-07-01 2019-10-31 Curemark Llc Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
EP2165717A1 (fr) * 2008-08-27 2010-03-24 Nordmark Arzneimittel GmbH & Co.KG Procédé de réduction de la charge virale et microbienne d'extraits biologiques contenant de la matière solide
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
JP5684725B2 (ja) 2009-01-06 2015-03-18 キュレロン リミテッド ライアビリティ カンパニー 黄色ブドウ球菌感染の治療または予防のための組成物および方法ならびに表面上にいる黄色ブドウ球菌の根絶または低減のための組成物および方法
CA2747703C (fr) 2009-01-06 2021-06-15 Curemark Llc Compositions et methodes de traitement ou de prevention d'infections par e. coli
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
EA029101B1 (ru) 2010-10-01 2018-02-28 Апталис Фарма Лимитид Составы с низкой дозой панкрелипазы и кишечнорастворимым покрытием
DK2701733T3 (da) 2011-04-21 2019-05-27 Curemark Llc Forbindelser til behandling af neuropsykiatriske forstyrrelser
CA2843556A1 (fr) 2011-08-08 2013-02-14 Aptalis Pharma Ltd. Procede de test de dissolution de compositions solides contenant des enzymes digestives
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US20160108389A1 (en) * 2013-07-22 2016-04-21 Aptalis Pharma Ltd. High potency pancreatin pharmaceutical compositions
CA2919114A1 (fr) * 2013-07-22 2015-02-12 Aptalis Pharma Ltd. Compositions pharmaceutiques de pancreatine de puissance elevee
EP3639846B1 (fr) 2013-08-09 2022-09-28 Allergan Pharmaceuticals International Limited Composition d'enzymes digestives appropriée pour une administration entérale
EP3003360B1 (fr) * 2013-11-05 2020-10-07 Allergan Pharmaceuticals International Limited Compositions pharmaceutiques de pancréatine de haute puissance
EP3157568A1 (fr) 2014-06-19 2017-04-26 Aptalis Pharma Limited Procédés d'élimination de contaminants viraux dans des extraits pancréatiques
CN114917328B (zh) 2014-11-05 2025-06-20 雅培制药股份有限公司 用于生产具有改善的安全特性的具有脂肪酶活性的组合物和适用于药物用途的组合物的方法
ES2970869T3 (es) 2016-03-28 2024-05-31 Abbott Laboratories Gmbh Composiciones enzimáticas con contaminación vírica y microbiana reducida
US11278603B2 (en) 2016-03-28 2022-03-22 Abbvie Inc. Enzyme compositions with reduced viral and microbial contamination
WO2018191233A1 (fr) 2017-04-10 2018-10-18 Curemark, Llc Compositions pour le traitement de l'accoutumance
BR112020006211A2 (pt) 2017-09-27 2020-10-13 Abbott Laboratories Gmbh preparação de enzima produzida por um método, preparação de enzima, método para produzir um produto de pancreatina, composição farmacêutica e método para tratar insuficiência pancreática exócrina
CN108316036A (zh) * 2018-01-25 2018-07-24 陕西科技大学 一种豆渣制备微纤化纤维素的方法
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
WO2024105193A1 (fr) * 2022-11-17 2024-05-23 Koptyug Andrey V Nouveaux composés et procédés

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3223594A (en) * 1960-10-25 1965-12-14 Philips Corp Method of producing pancreatin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1328202A (en) 1969-06-17 1973-08-30 Union International Co Ltd Manufacture of pancreatin
DE2106706B2 (de) * 1971-02-12 1973-05-10 Wilson Pharmaceutical & Chemical Corp., Chicago, 111. (V.St.A.) Verfahren zur herstellung von pankreatin als trockenes pulver mit hoher proteolytischer, amylolytischer und lipolytischer aktivitaet
DE2620289C2 (de) * 1976-05-07 1982-05-19 A. Nattermann & Cie GmbH, 5000 Köln Herstellung eines lipasereichen Enzympräparates
US4088539A (en) 1976-05-07 1978-05-09 A. Nattermann & Cie Gmbh Process of manufacturing enzyme preparation rich in lipase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3223594A (en) * 1960-10-25 1965-12-14 Philips Corp Method of producing pancreatin

Also Published As

Publication number Publication date
HU196435B (en) 1988-11-28
DK605583A (da) 1984-07-01
AR232000A1 (es) 1985-04-30
DD212981A5 (de) 1984-08-29
ES8407516A1 (es) 1984-09-16
YU252483A (en) 1986-10-31
US4623624A (en) 1986-11-18
YU45584B (sh) 1992-07-20
SU1644712A3 (ru) 1991-04-23
PL141118B1 (en) 1987-06-30
DE3377506D1 (en) 1988-09-01
BR8307280A (pt) 1984-08-07
DK605583D0 (da) 1983-12-29
EP0115023A2 (fr) 1984-08-08
CA1208580A (fr) 1986-07-29
ES528537A0 (es) 1984-09-16
DK173599B1 (da) 2001-04-23
EP0115023B1 (fr) 1988-07-27
EP0115023A3 (en) 1986-04-09
UA5996A1 (uk) 1994-12-29
PL245381A1 (en) 1984-10-22

Similar Documents

Publication Publication Date Title
UA5996A1 (uk) Спосіб одержання панкреотину з підшлункової залози
EP0171086B1 (fr) Procédé pour purifier le virus de l'influenza
RO90639B (ro) Procedeu pentru prepararea tesutului uman activator de plasminogen
SE9302996D0 (sv) Homogen och stabil cerealiesuspension
US4793996A (en) Method of making soybean extract inhibitor
GB1537509A (en) Method of preparing a component consisting of sugar lipid and protein derived from pseudomonas aeruginosa which possesses anti-tumor and interferon-inducing properties
Yamasaki et al. Purification and crystallization of α-glucosidase from Mucor javanicus
EP0116232B1 (fr) Agent antitumoral et son procédé de préparation
GB1575545A (en) Tumour antigen and process for the preparation thereof
US2808362A (en) Preparation of hyaluronidase
EP0110688B1 (fr) Production de facteurs angiogéniques
FR2672895A1 (fr) Procede de purification d'une proteine fortement glycosylee.
EP0301374A2 (fr) Procédé pour la purification de la protéine PP4 du tissu placentaire
US4136168A (en) Process for the preparation of neuraminidase from viral sources and methods of utilizing same
RU2041715C1 (ru) Биологически активное средство, способ его получения, препарат, содержащий указанное средство, и способ использования препарата
Loos et al. Cell-wall-bound lytic activity in Chlorella fusca: function and characterization of an endo-mannanase
Kurosaki et al. Phytoalexin production in cultured carrot cells treated with pectinolytic enzymes
US3660238A (en) Extraction of asparaginase from bacterial culture
JP3331870B2 (ja) 水溶性多糖類の製造法
Oleson et al. Nuclease I from suspension-cultured Nicotiana tabacum: purification and properties of the extracellular enzyme
Hurst A rapid method for the large scale preparation of calf thymus deoxyribonucleate
US4495096A (en) Process for producing and obtaining anaphylatoxin-and cocytotaxin-containing leucotaxine preparations and of anaphylatoxin and cocytotaxin proteins in molecularly homogeneous, biologically active form
JP3683912B2 (ja) 細胞組成物
RU2130070C1 (ru) Способ получения пероксидазы
DE3907162C2 (fr)